Chromogenic in-situ hybridization
Chromogenic in-situ hybridization (CISH) is emerging as a practical, cost-effective, and valid alternative to fluorescent in situ hybridization in testing for gene alteration, especially in centers primarily working with immunohistochemistry (IHC).
Epstein Barr Virus (EBV)
EBV is directly associated with various human cancers of epithelial, mesenchymal and especially lymphoid origin inside whose cells can be identified. The International Agency for Research on Cancer (IARC) lists EBV as a human carcinogen.
EBER Probe-Golden Standard for EBV Testing
EBER probe is an oligonucleotide-based probe that binds to the EBV-encoded small RNAs in nucleus. The probe is conjugated with Digoxin or biotin which can serve as antigen to be affixed by primary antibody.
Note: Products not for sale or use in the United States. For export only.
VC® EBER Detection Kit (CISH) is intended for the detection of nucleic acid targets on in-situ hybrid cell tissue, to provide physicians with auxiliary information for diagnosis.
- Shelf life: 12 months at 2-8 ℃
VC® EBER/CD3 Dual-staining Detection Kit is intended for the In-situ hybridization and immunohistochemical staining on the basis of HE staining, to provide physicians with auxiliary information for diagnosis.
- Shelf life: 12 months at 2-8 ℃
| Ordering information | ||
| Product | Sure Cat. No. | Specification |
| EBER/CD3 Dual-staining Detection Kit | VC07X0201 | 10, 20, 50 Tests/Kit |
| EBER Detection Kit (CISH) | VC07X0301 | 20, 50, 100 Tests/Kit |